Vaccination strategies for Korean patients with inflammatory bowel disease

키워드

참고문헌 (84)

1. Ng SC, "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies", Lancet, 390, pp.2769~2778 (2017)
2. Wee Khoon Ng, "Changing epidemiological trends of inflammatory bowel disease in Asia", Intestinal research, 14(2), pp.111~119 (2016), 대한장연구학회
3. Daren Low, "Landscape of inflammatory bowel disease in Singapore", Intestinal research, 20(3), pp.291~296 (2022), 대한장연구학회[DOI]
4. Manser CN, "Vaccination in patients with inflammatory bowel diseases", Digestion, 101(Suppl 1), pp.58~68 (2020)
5. Jong Pil Im, "Changing treatment paradigms for the management of inflammatory bowel disease", The Korean Journal of Internal Medicine, 33(1), pp.28~35 (2018), 대한내과학회[DOI]
6. Yoon Suk Jung, "Impact of early anti-TNF use on clinical outcomes in Crohn’s disease: a nationwide population-based study", The Korean Journal of Internal Medicine, 35(5), pp.1104~1113 (2020), 대한내과학회[DOI]
7. Hyo Sun Lee, "Novel treatments for inflammatory bowel disease", The Korean Journal of Internal Medicine, 33(1), pp.20~27 (2018), 대한내과학회[DOI]
8. Seung Wook Hong, "Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease", The Korean Journal of Internal Medicine, 36, pp.9~17 (2021), 대한내과학회[DOI]
9. Torres J, "ECCO guidelines on therapeutics in Crohn’s disease : medical treatment", J Crohns Colitis, 14, pp.4~22 (2020)
10. 박지혜, "Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?", Intestinal research, 20(1), pp.1~2 (2022), 대한장연구학회[DOI]
11. Arshdeep Singh, "Use of thiopurines in inflammatory bowel disease: an update", Intestinal research, 20(1), pp.11~30 (2022), 대한장연구학회[DOI]
12. Katsuyoshi Matsuoka, "Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis", Intestinal research, 21(1), pp.88~99 (2023), 대한장연구학회[DOI]
13. Benchimol EI, "Canadian Association of Gastroenterology Clinical Practice Guideline for immunizations in patients with inflammatory bowel disease(IBD)-Part 1 : live vaccines", Gastroenterology, 161, pp.669~680 (2021)
14. Jones JL, "Canadian Association of Gastroenterology Clinical Practice Guideline for immunizations in patients with inflammatory bowel disease(IBD)-Part 2 : inactivated vaccines", Gastroenterology, 161, pp.681~700 (2021)
15. Kucharzik T, "ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease", J Crohns Colitis, 15, pp.879~913 (2021)
16. Caldera F, "Vaccination in patients with inflammatory bowel disease", Am J Gastroenterol, 115, pp.1356~1361 (2020)
17. Wasan SK, "Immunization rates and vaccine beliefs among patients with inflammatory bowel disease : an opportunity for improvement", Inflamm Bowel Dis, 20, pp.246~250 (2014)
18. Lamb CA, "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults", Gut, 68(Suppl 3), pp.s1~s106 (2019)
19. Bernice Tan, "Pediatric to adult inflammatory bowel disease transition: the Asian experience", Intestinal research, 18(1), pp.11~17 (2020), 대한장연구학회
20. Liver Secrets Plus, "GI", pp.2015, Horton HA
21. Zullow S, "Updates on vaccinating the inflammatory bowel disease patient", Expert Rev Gastroenterol Hepatol, 13, pp.229~239 (2019)
22. Petrovsky N, "Vaccine adjuvants : current state and future trends", Immunol Cell Biol, 82, pp.488~496 (2004)
23. Croce E, "Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation : a systematic review of randomized trials, observational studies and case reports", Vaccine, 35, pp.1216~1226 (2017)
24. Rubin LG, "2013 IDSA clinical practice guideline for vaccination of the immunocompromised host", Clin Infect Dis, 58, pp.309~318 (2014)
25. Farraye FA, "ACG clinical guideline : preventive care in inflammatory bowel disease", Am J Gastroenterol, 112, pp.241~258 (2017)
26. Khan N, "Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases : a nationwide cohort study", Clin Gastroenterol Hepatol, 16, pp.1919~1927 (2018)
27. The Korean Society of Infectious Diseases, "Vaccinations for Adults" (2019), Koonja Publishing Inc.
28. "IBD care vaccination check list" (2022)[URL]
29. Long MD, "Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease", Aliment Pharmacol Ther, 37, pp.420~429 (2013)
30. Caldera F, "Using number needed to harm to put the risk of herpes zoster from tofacitinib in perspective", Inflamm Bowel Dis, 25, pp.955~957 (2019)
31. Tinsley A, "Increased risk of influenza and influenza-related complications among 140, 480patients with inflammatory bowel disease", Inflamm Bowel Dis, 25, pp.369~376 (2019)
32. Hagihara Y, "Infliximab and", or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease, 2014, pp.8, 223~233
33. Launay O, "Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and", or biologics : a two-year prospective study, 2015, pp.9, 1096~1107
34. Melmed GY, "Winter is coming! : clinical, immunologic, and practical considerations for vaccinating patients with inflammatory bowel disease during the coronavirus disease-2019 pandemic", Gastroenterology, 160, pp.639~644 (2021)
35. 이유진, "SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID", Intestinal research, 20(2), pp.171~183 (2022), 대한장연구학회[DOI]
36. Long MD, "Increased risk of pneumonia among patients with inflammatory bowel disease", Am J Gastroenterol, 108, pp.240~248 (2013)
37. Kantso B, "Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease : a nationwide Danish cohort study 1977-2013", Am J Gastroenterol, 110, pp.1582~1587 (2015)
38. Case DJ, "Pneumococcal vaccination rates in VHA patients with inflammatory bowel disease", Medicine(Baltimore), 94, pp.e417~ (2015)
39. Melmed GY, "Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease", Am J Gastroenterol, 105, pp.148~154 (2010)
40. Dotan I, "Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines", Inflamm Bowel Dis, 18, pp.261~268 (2012)
41. 임선영, "The epidemiology of hepatitis B virus infection in Korea", The Korean Journal of Internal Medicine, 34(5), pp.945~953 (2019), 대한내과학회[DOI]
42. Papa A, "Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents", J Crohns Colitis, 7, pp.113~119 (2013)
43. Loras C, "Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain : a nationwide, multicenter study", Am J Gastroenterol, 104, pp.57~63 (2009)
44. Parnita Harsh, "Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India", Intestinal research, 15(1), pp.97~102 (2017), 대한장연구학회
45. 김은수, "Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia", Intestinal research, 15(1), pp.5~6 (2017), 대한장연구학회
46. 여승재, "Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease", Intestinal research, 16(3), pp.400~408 (2018), 대한장연구학회
47. Kim ES, "Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area : inadequate protective antibody levels in young patients", J Clin Gastroenterol, 48, pp.553~558 (2014)
48. Loras C, "Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy", Gut, 59, pp.1340~1346 (2010)
49. Lee Ji Min, "Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease", Gut and Liver, 16(3), pp.396~403 (2022), 거트앤리버 소화기연관학회협의회[DOI]
50. Soo-Kyung Park, "Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 18(1), pp.18~33 (2020), 대한장연구학회
51. Vida Perez L, "Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease", Med Clin(Barc), 132, pp.331~335 (2009)
52. Caldera F, "Lower sustained diphtheria and pertussis antibody concentrations in inflammatory bowel disease patients", Dig Dis Sci, 63, pp.1532~1540 (2018)
53. Jiang HY, "Immune response to hepatitis B vaccination among people with inflammatory bowel diseases : a systematic review and meta-analysis", Vaccine, 35, pp.2633~2641 (2017)
54. Hee Seung Hong, "Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases", The Korean Journal of Internal Medicine, 37(1), pp.73~84 (2022), 대한내과학회[DOI]
55. Meites E, "Human papillomavirus vaccination for adults : updated recommendations of the Advisory Committee on Immunization Practices", MMWR Morb Mortal Wkly Rep, 68, pp.698~702 (2019)
56. Crosby S, "Vaccination of patients with inflammatory bowel disease during the COVID-19pandemic", Gastroenterol Hepatol(N Y), 17, pp.18~30 (2021)
57. Jacobson DL, "Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease", Inflamm Bowel Dis, 19, pp.1441~1449 (2013)
58. Dezfoli S, "Combined immunosuppression impairs immunogenicity to tetanus and pertussis vaccination among patients with inflammatory bowel disease", Inflamm Bowel Dis, 21, pp.1754~1760 (2015)
59. Cullen G, "Varicella zoster virus infection in inflammatory bowel disease", Inflamm Bowel Dis, 18, pp.2392~2403 (2012)
60. Leung VS, "Disseminated primary varicella after initiation of infliximab for Crohn’s disease", Am J Gastroenterol, 99, pp.2503~2504 (2004)
61. Marin AC, "Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease", World J Gastroenterol, 21, pp.11273~11281 (2015)
62. Freedman M, "Recommended adult immunization schedule, United States, 2020", Ann Intern Med, 172, pp.337~347 (2020)
63. Nugent Z, "Herpes zoster infection and herpes zoster vaccination in a population-based sample of persons with IBD : is there still an unmet need?", Inflamm Bowel Dis, 25, pp.532~540 (2019)
64. Chang K, "Increased risk of herpes zoster infection in patients with inflammatory bowel diseases in Korea", Clin Gastroenterol Hepatol, 16, pp.1928~1936 (2018)
65. Hosim Soh, "Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study", Gut and Liver, 13(3), pp.333~341 (2019), 거트앤리버 소화기연관학회협의회[DOI]
66. Winthrop KL, "Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib", Inflamm Bowel Dis, 24, pp.2258~2265 (2018)
67. Hanauer SB, "IM-UNITI : threeyear efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn’s disease", J Crohns Colitis, 14, pp.23~32 (2020)
68. Colombel JF, "The safety of vedolizumab for ulcerative colitis and Crohn’s disease", Gut, 66, pp.839~851 (2017)
69. James SF, "Shingrix : the new adjuvanted recombinant herpes zoster vaccine", Ann Pharmacother, 52, pp.673~680 (2018)
70. Berkowitz EM, "Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults : a phase 1", 2a randomized, placebo-controlled study, 2015, pp.211, 1279~1287
71. Vink P, "Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant : a phase 3, randomized clinical trial", Clin Infect Dis, 70, pp.181~190 (2020)
72. "Shingrix Recommendations" (2022)[URL]
73. Lee Yoo Jin, "Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis", Gut and Liver, 16(1), pp.81~91 (2022), 거트앤리버 소화기연관학회협의회[DOI]
74. 김경옥, "Management of inflammatory bowel disease in the COVID-19 era", Intestinal research, 20(1), pp.3~10 (2022), 대한장연구학회[DOI]
75. Hadi Y, "Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease : propensity matched research network analysis", Aliment Pharmacol Ther, 55, pp.191~200 (2022)
76. Anupam K. Singh, "Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis", Intestinal research, 20(1), pp.134~143 (2022), 대한장연구학회[DOI]
77. Bruna Barbosa da Luz, "An overview of the gut side of the SARS-CoV-2 infection", Intestinal research, 19(4), pp.379~385 (2021), 대한장연구학회[DOI]
78. Alexander JL, "SARS-CoV-2 vaccination for patients with inflammatory bowel disease : a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement", Lancet Gastroenterol Hepatol, 6, pp.218~224 (2021)
79. Siegel CA, "SARS-CoV-2vaccination for patients with inflammatory bowel diseases : recommendations from an international consensus meeting", Gut, 70, pp.635~640 (2021)
80. Botwin GJ, "Adverse events after SARSCoV-2 mRNA vaccination among patients with inflammatory bowel disease", Am J Gastroenterol, 116, pp.1746~1751 (2021)
81. Lev-Tzion R, "COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation", Clin Gastroenterol Hepatol, 20, pp.e1263~e1282 (2022)
82. Kennedy NA, "Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1nCoV-19 SARS-CoV-2 vaccines in patients with IBD", Gut, 70, pp.1884~1893 (2021)
83. Lin S, "Antibody decay, T cell immunity and breakthrough infections following two SARSCoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab", Nat Commun, 13, pp.1379~ (2022)
84. "COVID-19 Vaccines for Moderately or Severely Immunocompromised People" (2022)[URL]

관련 논문AI추천